Last reviewed · How we verify
Atorvastatin 10mg
At a glance
| Generic name | Atorvastatin 10mg |
|---|---|
| Also known as | Lipitor, Lipitor 10mg(Atorvastatin Sodium), statin, Lipinon Tab. 10mg, Active control group |
| Sponsor | Copenhagen University Hospital, Hvidovre |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Atorvastatin Therapy on Xanthoma in Alagille Syndrome (PHASE4)
- Vascular Endothelial Dysfunction in Sleep Apnea (PHASE1)
- [Effects of Selected Statins on Cardiovascular Parameters in Healthy Volunteers] (PHASE1)
- Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers (PHASE1)
- Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis (PHASE2)
- Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period (PHASE4)
- Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome (NA)
- Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Atorvastatin 10mg CI brief — competitive landscape report
- Atorvastatin 10mg updates RSS · CI watch RSS
- Copenhagen University Hospital, Hvidovre portfolio CI